LECOM Health

plaque

LECOM Health Cardiologist Pioneers Revolutionary Peripheral Arterial Disease Treatment in Western Pennsylvania

LECOM Health Cardiologist Pioneers Revolutionary Peripheral Arterial Disease Treatment in Western Pennsylvania

First-in-region SEISMIQ™ procedure offers new hope for patients facing amputation risk Erie, Pa. (June 4, 2026) — In a groundbreaking medical achievement, LECOM Health Interventional Cardiologist Matthew C. Becker, M.D., today successfully performed the first SEISMIQ™ Intravascular Lithotripsy (IVL) system procedure in Western Pennsylvania, marking a revolutionary advancement in treating Peripheral Arterial Disease (PAD). The cutting-edge SEISMIQ procedure addresses one of cardiology’s most challenging problems: calcified arterial blockages that resist traditional treatment methods. Unlike typical...Read More »

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

FDA-approved treatments administered as intravenous infusions Erie, Pa. (March 18, 2025) — LECOM Health is the first healthcare provider in the Erie region to offer amyloid-targeting therapies (ATT), which are monoclonal antibodies aimed at the amyloid-beta cascade for the treatment of early symptomatic Alzheimer’s Disease. FDA-approved medications being administered are Leqembi and Kisunla, which target the biomarkers related to AD and potentially slow the decline of the disease. Medication is administered as a 30-minute to...Read More »

Looking for assistance?

This is default text for notification bar